David E. Nix
Impact in
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
-
- Antibiotic Use and Resistance
Papers in
- Pharmacology 65
- Antibiotics Pharmacokinetics and Efficacy 65
- Pharmacogenetics and Drug Metabolism 21
-
- Antibiotic Use and Resistance 11
- Co-authors
- Jerome J. Schentag (33 shared papers)Alan Forrest (7 shared papers)Mary C. Birmingham (3 shared papers)Charles H. Ballow (2 shared papers)Charles A. Peloquin (12 shared papers)Thomas F. Goss (2 shared papers)Ahmad Aljada (1 shared paper)Claude Bohuon (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (25 papers)Annals of Pharmacotherapy (12 papers)American Journal of Health-System Pharmacy (9 papers)Open Forum Infectious Diseases (9 papers)Journal of Antimicrobial Chemotherapy (8 papers)
- Partner nations
- United StatesSaudi ArabiaUnited Kingdom
In The Last Decade
David E. Nix
135 papers receiving 5.7k citations
David E. Nix's Hit Papers
Peers
Comparison fields: 5 of 120
- Pharmacology 2.3k
- Applied Microbiology and Biotechnology 266
- Pharmacology 557
- Infectious Diseases 831
- Epidemiology 1.4k
Countries citing papers authored by David E. Nix
This map shows the geographic impact of David E. Nix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Nix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Nix more than expected).
Fields of papers citing papers by David E. Nix
This network shows the impact of papers produced by David E. Nix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Nix. The network helps show where David E. Nix may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Nix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients Hit paper breakdown → | 1993 | 985 |
| 2 | Procalcitonin increase after endotoxin injection in normal subjects Hit paper breakdown → | 1994 | 824 |
| 3 | 2006 | 241 | |
| 4 | 2013 | 206 | |
| 5 | 1989 | 162 | |
| 6 | 1991 | 154 | |
| 7 | 1999 | 150 | |
| 8 | 1991 | 125 | |
| 9 | 1993 | 125 | |
| 10 | 2004 | 122 | |
| 11 | 1990 | 121 | |
| 12 | 1995 | 119 | |
| 13 | 1999 | 100 | |
| 14 | 2004 | 95 | |
| 15 | 2009 | 89 | |
| 16 | 1989 | 88 | |
| 17 | 1995 | 87 | |
| 18 | 1990 | 83 | |
| 19 | Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids. | 1999 | 78 |
| 20 | 2009 | 78 |
About David E. Nix
David E. Nix is a scholar working on Pharmacology, Pharmacology, Applied Microbiology and Biotechnology, Infectious Diseases and Nephrology, having authored 139 papers that have together received 6.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (65 papers), Pharmacogenetics and Drug Metabolism (21 papers), Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (11 papers), Antibiotic Use and Resistance (11 papers), Acute Kidney Injury Research (5 papers), Chronic Kidney Disease and Diabetes (5 papers) and Surgical site infection prevention (5 papers). The work is most often cited by research in Pharmacology (2.3k citations), Applied Microbiology and Biotechnology (266 citations), Pharmacology (557 citations), Infectious Diseases (831 citations) and Epidemiology (1.4k citations). David E. Nix has collaborated with scholars based in United States, Saudi Arabia and United Kingdom. Frequent co-authors include Jerome J. Schentag, Alan Forrest, Mary C. Birmingham, Charles H. Ballow, Charles A. Peloquin, Thomas F. Goss, Ahmad Aljada, Claude Bohuon, Michael F. Wilson and Marcel Assicot. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Annals of Pharmacotherapy, American Journal of Health-System Pharmacy, Open Forum Infectious Diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.